Individual and joint effects of metformin and statins on mortality among patients with high‐risk prostate cancer

Individual and joint effects of metformin and statins on mortality among patients with high‐risk prostate cancer

Abstract Background Pre‐clinical studies suggest that metformin and statins may delay prostate cancer (PCa) metastases; however, data in humans are limited. To the best of our knowledge, this is the first human study aimed to quantify the individual and joint effects of statin and metformin use amon...

Full description

Bibliographic Details
Main Authors: Xiang‐Lin Tan, Jian‐Yu E, Yong Lin, Timothy R. Rebbeck, Shou‐En Lu, Mingyi Shang, William K. Kelly, Anthony D'Amico, Mark N. Stein, Lanjing Zhang, Thomas L. Jang, Isaac Yi Kim, Kitaw Demissie, Anna Ferrari, Grace Lu‐Yao
Format: Article
Language:English
Published: Wiley 2020-04-01
Series:Cancer Medicine
Subjects:
all‐cause mortality
high‐risk prostate cancer
metformin
population‐based cohort
prostate‐cancer mortality
statins
Online Access:https://doi.org/10.1002/cam4.2862

Internet

https://doi.org/10.1002/cam4.2862

Similar Items